02561 維昇藥業-B
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
24/04/2025盧安邦1312(S)-1,707,700(S)5,000,000(L)4.39
21/03/2025Vivo Plenilune IX Limited1711(L)37,167,064(L)37,167,064(L)32.62
21/03/2025Vivo Plenilune IX Limited1001(L)36,136,364(L)36,136,364(L)32.14
21/03/2025Vivo Capital Fund IX(Cayman), L.P.1001(L)36,136,364(L)36,136,364(L)32.14
21/03/2025Ascendis Pharma Endocrinology Division A/S1701(L)20,568,182(L)18.05
21/03/2025Ascendis Pharma Bone Diseases A/S1701(L)12,855,114(L)11.28
21/03/2025Ascendis Pharma A/S1701(L)41,136,364(L)36.11
21/03/2025盧安邦1701(L)
1313(S)
+5,000,000(L)
+1,707,700(S)
5,000,000(L)
1,707,700(S)
4.39
1.49
21/03/2025Ascendis Pharma Growth Disorders A/S1701(L)7,713,068(L)6.77
21/03/2025Vivo Capital IX (Cayman), LLC1001(L)36,136,364(L)36,136,364(L)32.14
21/03/2025Vivo Capital Fund IX(Cayman), L.P.1711(L)37,167,064(L)37,167,064(L)32.62
21/03/2025Vivo Capital IX (Cayman), LLC1711(L)37,167,064(L)37,167,064(L)32.62
 1  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.